Halma (HLMAF) has garnered a consensus "Moderate Buy" rating from eleven analysts, reflecting a mixed but generally positive outlook. While recommendations range from sell to strong buy, recent analyst actions highlight divergent views, with Zacks downgrading to a "hold" while Goldman Sachs upgraded the stock to a "strong-buy." This indicates ongoing scrutiny and varying conviction levels among institutional research firms regarding the technology solutions provider.
Halma (HLMAF) has garnered a consensus "Moderate Buy" rating from eleven covering analysts, indicating a generally positive, though mixed, outlook. This consensus is composed of one sell, five hold, two buy, and three strong buy recommendations, reflecting a broad range of professional opinions on the stock's future performance. The overall sentiment for the stock is categorized as "mildly positive" with a score of 0.35. Recent analyst actions underscore this divergence in views. Goldman Sachs Group upgraded Halma to a "strong-buy" in early August, while Zacks Research downgraded it from "strong-buy" to "hold" later that month. UBS Group restated a "buy" rating and Barclays reissued an "overweight" rating in late September, contrasting with Deutsche Bank's reaffirmed "hold" rating in early October. Despite the mildly positive analyst sentiment, Halma's stock experienced a 0.4% decline. The company operates across critical safety, health, and environmental technology markets, segmented into Safety, Environmental & Analysis, and Medical, suggesting a resilient business model within essential sectors.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment